Prime Capital Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
2,580
-72
| -3% | -$7.64K | ﹤0.01% | 793 |
|
|
2025
Q1 | $329K | Buy |
2,652
+27
| +1% | +$3.35K | ﹤0.01% | 805 |
|
|
2024
Q4 | $323K | Buy |
2,625
+6
| +0.2% | +$739 | ﹤0.01% | 705 |
|
|
2024
Q3 | $292K | Sell |
2,619
-2
| -0.1% | -$223 | ﹤0.01% | 745 |
|
|
2024
Q2 | $280K | Buy |
2,621
+36
| +1% | +$3.84K | ﹤0.01% | 744 |
|
|
2024
Q1 | $311K | Sell |
2,585
-61
| -2% | -$7.35K | ﹤0.01% | 764 |
|
|
2023
Q4 | $325K | Buy |
2,646
+108
| +4% | +$13.3K | ﹤0.01% | 712 |
|
|
2023
Q3 | $329K | Buy |
2,538
+16
| +0.6% | +$2.07K | 0.01% | 561 |
|
|
2023
Q2 | $313K | Buy |
+2,522
| New | +$313K | 0.01% | 594 |
|
|
2019
Q2 | – | Sell |
-186
| Closed | -$27K | – | 370 |
|
|
2019
Q1 | $27K | Buy |
+186
| New | +$27K | 0.01% | 222 |
|